DSP Nifty Healthcare Index Fund Direct-IDCW Reinvestment
Mutual Fund Details – Invest Smart, Grow Wealth
Discover a variety of mutual funds tailored to your goals, from equity and debt to hybrid options. Track performance, compare funds, and get expert insights to make informed investment decisions. Grow your wealth with Motilal Oswal’s trusted mutual fund solutions.
Equity, Sectoral-Pharma, Principal at very high risk
1 Year Return 0.0% at 22 Dec 2025 06:37 PM
Fund Details
NAV 10.4423
Sub-Type Sectoral-Pharma
Rating Not Rated
Min. SIP Amount ₹100.0
Fund Age(Year) 0.51
Fund Size(in Crores) 14.43
Fund Performance
1 Month -1.24%
3 Month -1.19%
6 Month 0.0%
1 Year 0.0%
3 Year 0.0%
5 Year 0.0%
Know This Fund
As on 22 Dec 2025
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (73.81%) Market Cap Small Cap 23.72 Mid Cap 21.71 Large Cap 28.38 Top Sectors Healthcare 73.81 Top Holding Glaxosmithkline Pharma 1.76 JB Chemicals 4.25 Mankind Pharma 1.93 Apollo Hospitals Enterprise 7.55 Onesource Specialty Pharma 1.05 Blue Jet Healthcare 0.6 Aster DM Healthcare 1.14 Pfizer 1.71 Aurobindo Pharma 1.26 Krishna Institute 1.41 Abbott India 1.03 Ajanta Pharma 2.85 Dr. Reddy's Laboratories 6.48 Dr. Lal Pathlabs 1.83 Glenmark Pharmaceuticals 2 Divi's Laboratories 5.55 Concord Biotech 0.49 Sai Life Sciences 1.82 Sun Pharmaceutical Industries 10.05 Syngene International 2.78 Max Healthcare Institute 6.18 Emcure Pharmaceuticals 1.94 Rainbow Children's 1.85 Cipla 6.3
Debt & Others (26.189999999999998%) Sector Allocation Net Payables -15.67 Margin Money 0.24 Reverse Repo 41.62 Debt Credit Ratings Debt Category Others 26.19
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M -1.69% Ret 1Y -2.44% Ret 3Y 21.06% Ret 5Y 13.62%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -2.33% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M -1.66% Ret 1Y -1.96% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 0% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M -2.13% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 0.24%
Exit Load 0%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Diipesh Shah
Education Mr. Shah is a B Com, ACA, Candidate of the CFA Program, CFA Institute USA, Level I Cleared
Experience Prior to joining DSP Mutual Fund, he has worked with JM Financial, Centrum Broking, IDFC Securities, ICICI Securities and IIFL Capital Pte Ltd Singapore.
Anil Ghelani
Education Mr. Ghelani has done B. Com., CFA & CA
Experience Prior to joining DSP Mutual Fund he has worked with IL&FS, S. R. Batliboi, V. C. Shah & Co.
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 0
Date of Incorporation 2025-06-20
Total AUM 2025-11-30
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.